Company intelligence / Profile preview

Genvio Pharma

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Genvio Pharma is a specialized pharmaceutical company headquartered in Dhaka, Bangladesh, dedicated to the development and manufacturing of high-quality, high-tech medicines. The company focuses primarily on oncology, hematology, virology, and CNS therapies, operating a state-of-the-art manufacturing facility designed to international EU-GMP and OEB-4 standards. Genvio's portfolio includes a broad range of branded generic targeted therapies and supportive care medications, aimed at making advanced treatments more affordable for patients globally. With a commitment to research and innovation, the firm serves both the domestic Bangladeshi market and international export markets.

Therapeutic areas: OncologyHematologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

5 assets

Treptora

Unknown

4 more assets in the full pipeline.

Beyond the preview

Go deeper on Genvio Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genvio Pharma.